Decisions about treatment should always be based on patients’ clinical needs. Clinical commissioning groups (CCGs) are required to commission healthcare services that meet the needs of their local population. To achieve this, they must assess local need, determining priorities and strategies, and commission services on behalf of their local population; overseeing those contracts to ensure high-quality care is provided.
National Health Service commissioners are legally required to fund treatments recommended in National Institute for Health and Care Excellence technology appraisal and highly specialised technologies guidance.
The future routine availability of any new or novel treatments would be subject to large scale clinical trials demonstrating the safety and efficacy of the treatment approach and subsequent assessments of its cost effectiveness for routine use.